This morning, Aurora Cannabis Inc. (TSXV:ACB)(OTC:ACBFF)announced that the company has received conditional approval to graduate from the TSX Venture Exchange and list its common shares on the TSX. When Aurora receives final approval to list on the TSX, shares will be voluntarily delisted from the TSX Venture Exchange prior to the commencement of trading on the TSX. Shares of Aurora will continue to trade on the TSX under the symbol "ACB".
Aurora Cannabis' CEO, Terry Booth
"Aurora's graduation to the TSX, for which we anticipate receiving final approval imminently, is another exciting milestone, reflecting our remarkable pace of growth and expansion, both across Canada and internationally. Since we began commercial operations 18 months ago, Aurora has established itself as a driving force, with one of the strongest brands in the cannabis industry, due to constant innovation and consistent execution. Tangible developments, such as the construction of Aurora Sky, our 100,000 kg per year cannabis production facility, the acquisitions in Québec and Germany, as well as our strategic investments in Cann Group in Australia, and Radient Technologies in Alberta, reflect how Aurora continues to set new standards in the industry. Having uplisted from the CSE to the TSXV in October, 2016, we believe that now graduating to the TSX will enable us to address an even wider investor audience, both domestically and internationally. We remain focused strongly on building shareholder value, and look forward to reporting on our progress as a member of Canada's flagship stock exchange."
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.